Related Experiment Video
Updated: Dec 2, 2025

08:40
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
17.9K
Circular RNA hsa_circ_0007364 increases cervical cancer progression through activating methionine adenosyltransferase
Hongfei Chen1, Bin Gu1, Xiang Zhao1
1Department of Anesthesia, Shanghai East Hospital, Tongji University School of Medicine , Shanghai, China.
Bioengineered
|November 3, 2020
Summary
Circular RNAs (circRNAs) like hsa_circ_0007364 are implicated in cervical cancer (CC). This study found hsa_circ_0007364 promotes CC progression by regulating the miR-101-5p/MAT2A axis, offering a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) are increasingly recognized for their roles in cancer development.
- The specific function of hsa_circ_0007364 in cervical cancer (CC) pathogenesis was previously undefined.
Purpose of the Study:
- To investigate the role and molecular mechanisms of hsa_circ_0007364 in cervical cancer.
- To determine if hsa_circ_0007364 could serve as a potential therapeutic target for CC.
Main Methods:
- Bioinformatics analysis and experimental validation were employed.
- Cell proliferation, invasion assays, and in vivo tumor growth studies were conducted.
- RNA immunoprecipitation and Western blot analyses were used to elucidate molecular interactions.
Main Results:
- Hsa_circ_0007364 was found to be upregulated in CC tissues and associated with advanced clinical features.
- Inhibition of hsa_circ_0007364 suppressed CC cell proliferation and invasion in vitro and reduced tumor growth in vivo.
- Hsa_circ_0007364 acts as a molecular sponge for miR-101-5p, and the miR-101-5p/MAT2A axis was identified as a key regulatory pathway.
Conclusions:
- Hsa_circ_0007364 functions as an oncogenic circRNA in cervical cancer progression.
- The hsa_circ_0007364/miR-101-5p/MAT2A axis represents a novel regulatory pathway in CC.
- Hsa_circ_0007364 inhibition presents a potential therapeutic strategy for cervical cancer treatment.
Related Concept Videos
MicroRNAs
3.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs
23.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.4K
Experimental RNAi
7.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.0K
Rous Sarcoma Virus (RSV) and Cancer
5.8K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.8K
lncRNA - Long Non-coding RNAs
9.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
siRNA - Small Interfering RNAs
17.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.9K

